We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 9 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 16 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 09. | Susquehanna | — | Downgrade | Positive → Neutral | — | Susquehanna: Positive → Neutral |
| 2026. 03. 26. | Argus Research | — | Downgrade | Buy → Hold | — | Argus Research: Buy → Hold |
| 2026. 03. 06. | Morgan Stanley | — | Downgrade | Overweight → Equal-Weight | — | Morgan Stanley: Overweight → Equal-Weight |
| 2026. 02. 27. | Seaport Global | — | Upgrade | Sell → Neutral | — | Seaport Global: Sell → Neutral |
| 2026. 02. 04. | Barclays | — | Downgrade | Overweight → Equal-Weight | — | Barclays: Overweight → Equal-Weight |
| 2026. 02. 04. | Jefferies | — | Maintain | Hold → Hold | — | Jefferies: Hold |
| 2025. 12. 05. | Argus Research | — | Upgrade | Hold → Buy | — | Argus Research: Hold → Buy |
| 2025. 11. 18. | Jefferies | — | Upgrade | Underperform → Hold | — | Jefferies: Underperform → Hold |
| 2025. 11. 07. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2025. 10. 23. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 10. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 13. | Susquehanna | — | Maintain | Positive → Positive | — | Susquehanna: Positive |
| 2025. 10. 07. | Evercore ISI Group | — | Initiate coverage | — → In-Line | — | Evercore ISI Group: In-Line |
| 2025. 07. 23. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 07. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 07. 21. | Susquehanna | — | Maintain | Positive → Positive | — | Susquehanna: Positive |
| 2025. 05. 27. | Argus Research | — | Downgrade | Buy → Hold | — | Argus Research: Buy → Hold |
| 2025. 05. 20. | Jefferies | — | Downgrade | Hold → Underperform | — | Jefferies: Hold → Underperform |
| 2025. 04. 25. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 04. 10. | Jefferies | — | Downgrade | Buy → Hold | — | Jefferies: Buy → Hold |
| 2025. 03. 06. | Susquehanna | — | Maintain | Positive → Positive | — | Susquehanna: Positive |
| 2025. 03. 05. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2025. 03. 04. | B of A Securities | — | Upgrade | Underperform → Neutral | — | B of A Securities: Underperform → Neutral |
| 2025. 03. 03. | Seaport Global | — | Downgrade | Neutral → Sell | — | Seaport Global: Neutral → Sell |
| 2025. 01. 27. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 12. 13. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 12. 13. | HSBC | — | Initiate coverage | — → Buy | — | HSBC: Buy |
| 2024. 11. 22. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2024. 11. 06. | Susquehanna | — | Maintain | Positive → Positive | — | Susquehanna: Positive |
| 2024. 10. 21. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 09. 12. | Jefferies | — | Initiate coverage | — → Buy | — | Jefferies: Buy |
| 2024. 07. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 06. 25. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 05. 21. | Seaport Global | — | Downgrade | Buy → Neutral | — | Seaport Global: Buy → Neutral |
| 2024. 05. 17. | Mizuho | — | Maintain | Buy → Buy | — | Mizuho: Buy |
| 2024. 05. 10. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2024. 04. 18. | Mizuho | — | Initiate coverage | — → Buy | — | Mizuho: Buy |
| 2024. 04. 09. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2024. 04. 04. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2024. 03. 27. | Argus Research | — | Maintain | Buy → Buy | — | Argus Research: Buy |